Navigation Links
NIH grant will boost electron microscopy at Brandeis
Date:10/7/2009

Waltham, MAResearchers' ability to rapidly detect the macromolecular protein clumps implicated in Alzheimer's and other neurodegenerative diseases will soon get a sizable boost in the lab of biochemist and Howard Hughes Medical Investigator Nikolaus Grigorieff. The National Institutes of Health has just awarded Grigorieff a $2.2 million grant for a second high-resolution electron microscope (EM) in his lab.

Grigorieff's lab studies the three-dimensional (3D) structure of proteins and protein complexes using electron cryo-microscopy, generally focusing on proteins that are difficult to study by more traditional techniques such as X-ray crystallography and nuclear magnetic resonance (NMR).

"This grant will enable my lab to do more high-resolution cryo-EM work of the kind we already do," said Grigorieff. The new EM, which will take the better part of a year to install in Grigorieff's Rosenstiel lab, includes a digital detector to collect image data more rapidly than the lab is currently able to using conventional film photography. As a result, the new microscope will also make it possible to accommodate the higher demand on the lab created by colleague Daniela Nicastro, who uses EM to study the molecular motors in flagella.

Earlier this year, Grigorieff and colleagues at the Leibniz Institute in Germany took an important step toward demystifying the way protein clumps form during the development of neurodegenerative disease. Using EM, the researchers showed a 3D image of a spaghetti-like protein mass called an amyloid fibril formed by the A-beta peptide in the brains of Alzheimer's patients.

Grigorieff said his lab made an image of the A-beta fibril at a resolution of eight Angstroms, revealing useful detail at a magnification of roughly a million times. Short of atomic resolution by a factor of 2.5 to 3, the image revealed how the peptide, a series of linked amino acids, was arranged in the tape-like fibril.

"People had been guessing for decades what these fibrils look like, but now we have an actual 3D image," said Grigorieff. Traditionally, the techniques of X-ray crystallography and solution NMR have been used to determine atomic structure, but these fibrils usually do not form crystals suitable for X-ray diffraction and are too large for solution NMR analysis. Under EM, however, proteins and protein complexes with molecular weights that range from a few thousand to several million Daltons can be visualized.

"The next step will be a 3D image that tells us exactly where all the amino acids are," postulates Grigorieff. "This will tell us more about the chemical and biological properties of A-beta fibrils that we need to know to understand their role in Alzheimer's."


'/>"/>

Contact: Laura Gardner
gardner@brandeis.edu
781-736-4204
Brandeis University
Source:Eurekalert

Related biology news :

1. Forsyth receives highly competitive challenge grants
2. ASCB wins NIH stimulus grant to build virtual library of cell images for researchers and public
3. UNC awarded Cancer Genome Atlas grant
4. Stimulus grant to fund whole-genome sequencing in children with autism
5. Delaware State U. receives $5 million NASA grant for optics research
6. PyroHands: NC State receives grant to develop next generation firefighter gloves
7. Louisiana Tech University receives grant to advance women in engineering, science
8. Scandinavians are descended from Stone Age immigrants
9. 2 neuroscientists from Cold Spring Harbor Laboratory awarded transformative NIH grants
10. IOF-AMGEN Health Professional Awareness Grants awarded at Beijing conference
11. Boston University engineer to use $2.5 million NIH grant to cells reaction to physical force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special Counsel to ... of Identity Strategy Partners, LLP, today releases the following ... Protecting the Nation From Foreign Terrorist Entry Into the ... Trump,s ,Travel Ban, Executive Order gains more notoriety and ... ban, it is important that our national discourse regain ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Feb. 24, 2017 Provectus Biopharmaceuticals, Inc. ... "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, ... to participate in its previously announced rights offering ... shares of common stock and Series C Convertible ... listed warrants. As previously announced, ...
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), ... announced its financial results for the fourth quarter and fiscal ... Highlights Total sales in the fourth ... increased by 13.6% in USD terms to $77.6 million from ... Gross profit increased by 13.3% to $46.8 million from ...
Breaking Biology Technology: